238 related articles for article (PubMed ID: 17301523)
1. [Ewing sarcoma].
Hamanoue S; Makimoto A
Gan To Kagaku Ryoho; 2007 Feb; 34(2):175-80. PubMed ID: 17301523
[TBL] [Abstract][Full Text] [Related]
2. Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience.
Moschovi M; Trimis G; Stefanaki K; Anastasopoulos J; Syriopoulou V; Koultouki E; Tzortzatou-Stathopoulou F
J Surg Oncol; 2005 Mar; 89(4):239-43. PubMed ID: 15726621
[TBL] [Abstract][Full Text] [Related]
3. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
[TBL] [Abstract][Full Text] [Related]
4. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
Krasin MJ; Davidoff AM; Rodriguez-Galindo C; Billups CA; Fuller CE; Neel MD; Merchant TE
Cancer; 2005 Jul; 104(2):367-73. PubMed ID: 15948159
[TBL] [Abstract][Full Text] [Related]
5. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
Milano GM; Cozza R; Ilari I; De Sio L; Boldrini R; Jenkner A; De Ioris M; Inserra A; Dominici C; Donfrancesco A
Cancer; 2006 Apr; 106(8):1838-45. PubMed ID: 16532434
[TBL] [Abstract][Full Text] [Related]
6. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
Yock TI; Krailo M; Fryer CJ; Donaldson SS; Miser JS; Chen Z; Bernstein M; Laurie F; Gebhardt MC; Grier HE; Tarbell NJ;
J Clin Oncol; 2006 Aug; 24(24):3838-43. PubMed ID: 16921035
[TBL] [Abstract][Full Text] [Related]
7. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Krasin MJ; Rodriguez-Galindo C; Billups CA; Davidoff AM; Neel MD; Merchant TE; Kun LE
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):830-8. PubMed ID: 15465200
[TBL] [Abstract][Full Text] [Related]
8. [Treatment for Ewing's sarcoma family of tumors in children].
Mugishima H; Chin M; Yokoyama R; Makimoto A
Nihon Geka Gakkai Zasshi; 2005 Jul; 106(7):437-43. PubMed ID: 16045188
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
La TH; Meyers PA; Wexler LH; Alektiar KM; Healey JH; Laquaglia MP; Boland PJ; Wolden SL
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):544-50. PubMed ID: 16198063
[TBL] [Abstract][Full Text] [Related]
10. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].
Ullmann C; Beck JD; Holter W; Petsch S; Dunst J; Sauer R; Grabenbauer GG
Strahlenther Onkol; 2008 Mar; 184(3):137-44. PubMed ID: 18330509
[TBL] [Abstract][Full Text] [Related]
11. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy.
Gupta AA; Pappo A; Saunders N; Hopyan S; Ferguson P; Wunder J; O'Sullivan B; Catton C; Greenberg M; Blackstein M
Cancer; 2010 Jul; 116(13):3189-94. PubMed ID: 20564643
[TBL] [Abstract][Full Text] [Related]
13. Chest wall Ewing sarcoma family of tumors: long-term outcomes.
Indelicato DJ; Keole SR; Lagmay JP; Morris CG; Gibbs CP; Scarborough MT; Islam S; Marcus RB
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):158-66. PubMed ID: 20732765
[TBL] [Abstract][Full Text] [Related]
14. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
Al-Faris N; Al Harbi T; Goia C; Pappo A; Doyle J; Gassas A
Pediatr Blood Cancer; 2007 Aug; 49(2):190-5. PubMed ID: 17262797
[TBL] [Abstract][Full Text] [Related]
15. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group.
Bernstein ML; Devidas M; Lafreniere D; Souid AK; Meyers PA; Gebhardt M; Stine K; Nicholas R; Perlman EJ; Dubowy R; Wainer IW; Dickman PS; Link MP; Goorin A; Grier HE; ; ;
J Clin Oncol; 2006 Jan; 24(1):152-9. PubMed ID: 16382125
[TBL] [Abstract][Full Text] [Related]
16. Current treatment for Ewing's sarcoma.
Thacker MM; Temple HT; Scully SP
Expert Rev Anticancer Ther; 2005 Apr; 5(2):319-31. PubMed ID: 15877528
[TBL] [Abstract][Full Text] [Related]
17. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
Paulino AC; Nguyen TX; Mai WY; Teh BS; Wen BC
Pediatr Blood Cancer; 2007 Aug; 49(2):145-8. PubMed ID: 16732580
[TBL] [Abstract][Full Text] [Related]
18. Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
Argon A; Basaran M; Yaman F; Dizdar Y; Sakar B; Camlica H; Bavbek SE; Ozger H; Darendeliler E; Onat H
Jpn J Clin Oncol; 2004 Nov; 34(11):667-72. PubMed ID: 15613556
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy in the multimodal management of Ewing's sarcoma of bone: report of the Intergroup Ewing's Sarcoma Study.
Perez CA; Tefft M; Nesbit ME; Burgert EO; Vietti TJ; Kissane J; Pritchard DJ; Gehan EA
Natl Cancer Inst Monogr; 1981 Apr; (56):263-71. PubMed ID: 7029294
[TBL] [Abstract][Full Text] [Related]
20. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
